Long-form research.
Mechanism · administration · safety.

BPC-157 and TB-500 are the most widely self-researched peptides in the recovery and healing space. BPC-157 was originally derived from a protein found in gastric juice and has shown remarkable tissue-repair properties in animal models — from torn tendons to gut ulcers to nerve injuries. TB-500 is a synthetic fragment of Thymosin Beta-4, a protein present in virtually every cell of the body that plays a central role in tissue repair and new blood vessel formation. Together they represent two distinct but complementary approaches to accelerating the body\'s natural healing processes. Both are available from EU-based research vendors and are among the most studied peptides in the self-research community.

Muscle growth peptide research focuses on compounds that stimulate the body\'s own muscle-building pathways — particularly the IGF-1/mTOR signalling axis and satellite cell activation. IGF-1 LR3 is a long-acting form of Insulin-like Growth Factor 1, a hormone naturally produced in the liver that drives muscle protein synthesis and satellite cell (muscle stem cell) proliferation. TB-500, also studied in the healing category, contributes here through its role in directing satellite cells to repair sites and improving blood supply to muscle tissue. These peptides are studied by researchers interested in skeletal muscle biology, hypertrophy mechanisms, and post-injury muscle recovery.

Semax and Selank are Soviet-era synthetic peptides developed in Russia during the 1970s–80s and still prescribed there today for stroke recovery, anxiety disorders, and cognitive decline. Unlike stimulants (which flood the brain with dopamine) or sedatives (which suppress neuronal activity), these peptides work by upregulating the brain\'s own growth and repair factors. Semax stimulates the production of BDNF — brain-derived neurotrophic factor — a protein critical for learning, memory, and neuronal survival. Selank modulates the GABA system, the brain\'s primary calming pathway, producing anxiolytic effects without the sedation or dependence risk of benzodiazepines. A key practical advantage: both are administered as nasal sprays, bypassing the need for injections.

Epithalon and GHK-Cu sit at the frontier of longevity science. Epithalon is a synthetic tetrapeptide developed by Russian gerontologist Vladimir Khavinson from pineal gland extracts. It is one of the very few compounds shown in peer-reviewed studies to activate telomerase — the enzyme responsible for repairing the ends of chromosomes — in human cell cultures. Longer telomeres are associated with slower cellular ageing and reduced age-related disease risk. GHK-Cu is a naturally occurring copper-peptide complex found in human plasma, saliva, and urine. Its concentration drops dramatically with age — from ~200 ng/mL at age 20 to under 80 ng/mL by age 60 — and it regulates an extraordinary number of biological processes including collagen production, antioxidant defence, anti-inflammatory signalling, and stem cell activation. Both peptides attract significant interest from the longevity research and biohacker communities.

Thymosin Alpha-1 stands apart from most research peptides by having the most robust clinical validation: it is an approved pharmaceutical (Zadaxin®) in over 35 countries including Italy, China, and various Asian and Eastern European nations. The thymus gland produces Thymosin Alpha-1 naturally to "educate" T-cells — white blood cells that coordinate the immune response. As we age, thymic output declines, and with it the efficiency of our immune surveillance. Thymosin Alpha-1 is studied to restore this immune competence: activating natural killer cells, boosting T-cell populations, and enhancing the body\'s response to vaccines and infections. It is of particular interest to self-researchers focused on immune optimisation, post-illness recovery, and age-related immune decline.

Weight loss peptide research centres on compounds that either directly break down fat cells or stimulate the body\'s own growth hormone — which drives fat burning, lean mass preservation, and metabolic health. AOD-9604 is an engineered fragment of human growth hormone designed specifically to activate fat-cell breakdown (lipolysis) without the blood sugar dysregulation or anabolic side-effects of full-length HGH. CJC-1295 and Ipamorelin are studied in combination: CJC-1295 signals the pituitary gland to produce more growth hormone, while Ipamorelin amplifies the resulting pulse — producing up to 5× more GH than either compound alone, with a highly selective profile that avoids the cortisol and prolactin increases seen with older GH-releasing peptides. Together, these compounds represent a sophisticated approach to metabolic research that goes well beyond simple calorie restriction. A separate, pharmaceutical class — the incretin analogues semaglutide, tirzepatide and retatrutide and the amylin analogue cagrilintide — acts on GLP-1, GIP, glucagon and amylin receptors; semaglutide and tirzepatide are approved prescription medicines, while research-labelled vials of any of the four are unapproved products outside that regulated supply chain.

Sleep quality is increasingly recognised as one of the most powerful levers for health, cognitive performance, and longevity. DSIP (Delta Sleep-Inducing Peptide) was discovered in 1977 when researchers isolated it from rabbit blood during natural sleep and found that injecting it into alert rabbits induced slow-wave (deep) sleep within 30 minutes. Unlike sleeping pills, which work by broadly suppressing brain activity, DSIP specifically promotes delta-wave (slow-wave) sleep — the deepest and most restorative stage — without sedation, respiratory depression, or dependence. Selank contributes to this category through its anxiolytic mechanism: by reducing the hyperarousal (racing thoughts, elevated cortisol, difficulty switching off) that underlies stress-induced insomnia, without the muscle-relaxing or respiratory effects of benzodiazepines.

PT-141, known clinically as Bremelanotide and sold as Vyleesi®, is the only FDA-approved peptide specifically for sexual dysfunction — approved in 2019 for hypoactive sexual desire disorder in premenopausal women. What makes PT-141 unique is where it acts: not in the blood vessels, like Viagra or Cialis, but in the brain. It activates melanocortin receptors in the hypothalamus — a region involved in desire, arousal, and motivation — producing an increase in sexual interest that is centrally driven rather than mechanically facilitated. This makes it relevant for addressing the desire and psychological components of sexual dysfunction, which PDE5 inhibitors cannot reach. It has been studied in both men and women, giving it one of the broadest clinical research bases of any peptide on this site.

PeptideGuide rates vendors on 5 weighted axes: Testing (30%), Purity (20%), Regional-Friendliness (15%), Value (15%), Trust (20%). Each axis has a publishable rubric. The composite score 0-10 produces regional leaderboards and Editor\'s Choice designations. The personalized finder applies axis multipliers per buyer-priority answer. Methodology is transparent and quarterly-reviewed. Affiliate commissions do NOT affect scoring.

A genuine CoA names the lab, the batch (lot number), the test methods used, and is signed/dated. Demand HPLC (purity %) AND LC-MS (identity confirmation via molecular mass) at minimum — without both, purity alone tells you nothing about WHAT is pure. CLND verifies absolute peptide content; LAL measures endotoxin (critical for injection research); FTIR confirms structural identity. Independent third-party lab CoAs (Janoshik Analytical, Eurofins, etc.) beat in-house CoAs. Per-batch CoA archive beats a single demo CoA. Apply the 8-item red flag checklist before ordering.

RUO ("research use only") is a regulatory positioning device. It places vendors outside pharmaceutical drug regulation and inside research-reagent regulation. It permits sale, advertising (restricted), shipping, and purchase for laboratory research. It does NOT permit therapeutic claims, dosing recommendations for human use, or sale to known therapeutic-use customers. It does NOT certify quality. It does NOT transfer legal use-protection to buyers. Regulatory treatment varies meaningfully across US (FDA), EU (EMA + national agencies), UK (MHRA), AU (TGA Schedule 4 — strictest), JP (PMD Act + import confirmation above personal-use limits), CA (Health Canada NPN/DIN exemption), GCC (SFDA/MoHAP/KFDA/NHRA), Africa (per-country: SAHPRA/NAFDAC/EDA/etc.), LATAM (ANVISA/COFEPRIS/ANMAT/INVIMA/ISP/DIGEMID), and Russia (Roszdravnadzor + sanctions overlay).

Reconstitution math: concentration (mg/mL) = peptide mass (mg) / volume added (mL). Common reconstitutions: 5mg vial + 1mL BAC water = 5mg/mL; 5mg + 2mL = 2.5mg/mL; 5mg + 2.5mL = 2mg/mL. Use bacteriostatic water (BAC water), insulin syringes, refrigerator storage 28-day window for reconstituted vials, refrigerator or freezer for lyophilized vials pre-reconstitution. Lyophilized peptides do NOT require cold-chain shipping — room-temperature international transit is operationally clean. Avoid tap water, distilled water for multi-day use, shaking during reconstitution, and high reconstitution temperatures.

4-stage supply chain: Synthesis (mostly Chinese manufacturers, some Slovakia/Cyprus/Spain/Vietnam) → Bulk purchase (vendors buy kilogram-scale) → Repackaging + CoA verification (where consumer-facing vendor differentiation actually happens) → Warehouse + shipping + customer service. Quality lives at stages 1-3, not stage 4. Most consumer vendors buy from the same upstream manufacturers — differentiation comes from testing depth, batch-level verification, and operating history. Particle Peptides (Slovakia) is the EU gold standard via vertical integration. Core Peptides (US) is the US gold standard via multi-lab third-party CoA verification compensating for non-vertical-integration. Weighting testing depth heavily is the buyer\'s rational response to the supply-chain structure.

WADA Prohibited List applies to tested athletes registered with WADA-Code-adopting federations (Olympic pathway, NCAA, World Athletics, FIFA, national teams in most sports). Most research peptides are banned: BPC-157 (S0 since 2022), TB-500 (S2.3), IGF-1 LR3 (S2.3), CJC-1295/Ipamorelin (S2.2.4), MGF (S2.3), AOD-9604 (S2.2.3), GHK-Cu injectable (S0). Strict liability — "I didn\'t know" is not a defense. First-violation bans run up to four years: two by default for S0 substances, four for S2. TUE structurally closed for research-grade compounds. Detection windows 2-10 weeks depending on compound. Out-of-competition testing means no "wash out" strategy is safe. Non-tested athletes (recreational, masters in non-WADA federations) face NO WADA enforcement.

Australia has one of the strictest research-peptide regimes in the English-speaking world. TGA Schedule 4 + Customs Act import controls + ABF interception combine to make personal-use research peptide import legally exposed. Institutional researchers should use the SAS pathway. Vendors with explicit AU customs warnings should be heeded.

ABF does intercept research peptide shipments, but PeptideGuide has no data on interception rates by origin, vendor or declaration, and no official source on what happens to individual buyers.

Sport Integrity Australia tests Australian athletes in major sports (AFL, NRL, cricket, etc) under WADA rules. Research peptides are prohibited under WADA S0; BPC-157 specified by name since 2022. First-offence bans are 2 years. Non-tested athletes are not subject to SIA but still under TGA / ABF.

QSC Peptides holds the 2026 AU Editor's Choice. Direct Peptides AU (7.6) and Pharma Lab Global (7.2, open incident on record) are the UK-origin alternatives. PeptideGuide has no data showing that any origin clears Australian Border Force more often.

Direct Peptides AU outscores Pharma Lab Global (7.6 vs 7.2) at competitive pricing for the most-traded peptides. Pharma Lab Global suits AU researchers prioritising operating history and a broad catalog, but has an open high-severity incident on record.

Pharma Lab Global (7.2/10) is the AU/NZ UK-import pick with HPLC + LC-MS tested COAs, tracked UK-AU shipping priced per country at checkout. Pricing in GBP. 11-year operating history.

SwissChems is a US-Arizona vendor shipping into Australia. HPLC + LC-MS testing, 99.3% purity. Cross-Pacific shipping 10-20 days. Segment-highest affiliate commission (20%, no cookie). Free shipping threshold USD $300 — high for AU buyers. QSC Peptides is the AU Editor's Choice; Pharma Lab Global and Direct Peptides are the UK-origin options.

Direct Peptides is the AU value-tier UK option — second on the AU leaderboard behind QSC Peptides. HPLC + LC-MS tested CoAs (matches Pharma Lab Global testing depth), no current Trustpilot rating (profile removed, September 2026), more competitive GBP pricing on specific products, free shipping over GBP £100. 9-year operating history.